Single nucleotide polymorphisms in TLR9 are highly associated with susceptibility to bacterial meningitis in children

Marieke S Sanders1, Gijs Th J van Well, Sander Ouburg

  • 1Department of Pathology, Laboratory for Immunogenetics, VU University Medical Center, Amsterdam, The Netherlands.

Abstract

Insights

Genetic variations in Toll-like receptor 9 (TLR9) single nucleotide polymorphisms (SNPs) are linked to bacterial meningitis (BM) susceptibility. The TLR9+2848-A allele shows a protective effect against meningococcal meningitis (MM).

Area of Science:

  • Immunology
  • Genetics
  • Infectious Diseases

Background:

  • Bacterial meningitis (BM) is a severe infection with variable genetic susceptibility.
  • Toll-like receptor 9 (TLR9) recognizes bacterial DNA, initiating inflammatory signaling.
  • Single nucleotide polymorphisms (SNPs) in TLR9 are linked to various diseases, but not previously to meningitis.

Purpose of the Study:

  • To investigate the association between TLR9 SNPs and host defense against bacterial meningitis.
  • To determine the role of specific TLR9 SNPs and haplotypes in susceptibility to meningococcal meningitis (MM).

Main Methods:

  • Genotyping of two TLR9 SNPs and four TLR9 haplotypes in 472 BM survivors and 392 healthy controls.
  • Statistical analysis including odds ratio (OR) and confidence interval (CI) calculation.
  • In silico analysis of Neisseria meningitidis (NM) DNA's immunoinhibitory potential upon TLR9 recognition.

Main Results:

  • The TLR9+2848-A mutant allele was significantly less frequent in MM patients (OR: 0.6, CI: 0.4-0.9).
  • TLR9 haplotype I was associated with increased MM susceptibility (OR: 1.3, CI: 1.0-1.5).
  • In silico analysis revealed a strong immunoinhibitory effect of NM CpG DNA on TLR9 signaling (CpG index: -106.8).

Conclusions:

  • TLR9 SNPs are associated with susceptibility to bacterial meningitis, particularly MM.
  • The TLR9+2848-A allele demonstrates a protective effect against MM.
  • This protective effect may stem from an up-regulated TLR9 immune response to NM CpG DNA.

Related Concept Videos

Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...